Site News

Added 7 hours ago Drug news

Oncologic Drugs Advisory Committee recommends Endari (l-glutamine) to treat sickle cell disease.-Emmaus Life Sciences Inc.

Emmaus Life Sciences Inc. announced that the Oncologic Drugs Advisory Committee of the FDA voted 10 to 3 that the...

Added 1 day ago Drug news

Sanofi announces CHMP recommendation for Insulin Lispro Sanofi (insulin lispro 100 Units/mL)a biosimilar for types 1 and 2 diabetes.

Sanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...

Added 1 day ago Drug news

European Commission grants standard marketing approval for Fampyra (prolonged-release fampridine tablets) to improve walking for MS patients on the basis of ENHANCE study.-Biogen

The European Commission (EC) has granted a standard marketing authorization for Fampyra (prolonged-release fampridine tablets) for walking improvement in people...

Added 1 day ago Drug news

Successful Phase III trial of Roclatan (netarsudil/latanoprost ophthalmic solution) to treat glaucoma or ocular hypertension. - Aerie Pharmaceuticals Inc.

Aerie Pharmaceuticals, Inc. reported the successful primary efficacy results of the Company's 90-day Phase III Mercury 2" registration trial for...

Added 2 days ago Drug news

NEJM publishes Phase III trial of Epidiolex (cannabidiol) in children with Dravet syndrome. - GW Pharma

GW Pharmaceuticals plc announced that The New England Journal of Medicine has published results from a Phase III study of...

Added 2 days ago Drug news

Abilify (aripiprazole) embedded with a Proteus ingestible sensor is re-filed at FDA.- Otsuka + Proteus Digital Health

Otsuka Pharmaceutical Co., Ltd. and Proteus Digital Health announce that the FDA has acknowledged receipt of the New Drug Application...

Added 2 days ago Drug news

EMA widens scope of Zebinix (eslicarbazepine acetate) for use as a once-daily monotherapy to treat adults with newly-diagnosed partial-onset epilepsy. - Bial + Eisai

The European Medicines Agency has approved the use of Zebinix (eslicarbazepine acetate) from Bial + Eisai for use as a...

Added 3 days ago Drug news

FDA accepts BLA from BMS for Opdivo (nivolumab) to treat hepatocellular carcinoma (liver cancer) after prior sorafenib therapy.

BMS has announced that the FDA accepted a supplemental Biologics License Application (sBLA) that seeks to extend the use of...

Added 3 days ago Drug news

New EMA ruling on use of antibiotic vancomycin.

The European Medicines Agency (EMA) has recommended changes to prescribing information for the antibiotic vancomycin to ensure appropriate use in...

Added 3 days ago Industry news

Bioverativ acquires True North Therapeutics and with it TNT 009 an innovative treatment for cold agglutinin disease.

Bioverativ Inc. a global biotechnology company which was spun out of Biogen , is focused on the discovery, development and...

View all news articles